Multiplex Automated Genome Engineering, or MAGE, is a genome editing technique that enables scientists to quickly edit an organism’s DNA to produce multiple changes across the genome. In 2009, two genetic researchers at the Wyss Institute at Harvard Medical School in Boston, Massachusetts, Harris Wang and George Church, developed the technology during a time when researchers could only edit one site in an organism’s genome at a time. Wang and Church called MAGE a form of accelerated evolution because it creates different cells with many variations of the same original genome over multiple generations. MAGE made genome editing much faster, cheaper, and easier for genetic researchers to create organisms with novel functions that they can use for a variety of purposes, such as making chemicals and medicine, developing biofuels, or further studying and understanding the genes that can cause harmful mutations in humans.

Charles Rotimi is a researcher who studies the etiology of complex diseases and health disparities and advocates for the inclusion of greater racial and ethnic diversity in genomic repositories. In the early 2000s, Rotimi spearheaded the recruiting of African communities for participation in the International HapMap Project. As director of the Center for Research on Genomics and Global Health, or CRGGH, at the National Institutes of Health, or NIH, Rotimi led governmental research on human genetic variation and patterns of disease. Rotimi is a founding member of the Human Heredity and Health in Africa, or H3Africa, initiative, which aims to increase the representation of African populations in global genetic studies. Through his epidemiological research, leadership in advocacy groups for the support of African scientists, and his collaboration in genomic diversity initiatives, Rotimi promotes racial and ethnic representation in genetic research, especially regarding the inclusion of African people and the African diaspora.